Actions and Detail Panel
OBN BioTuesday: Veterinary Science and Translational Medicine
Tue 6 June 2017, 18:00 – 21:30 BST
Kindly supported by Venner Shipley, this meeting will address the fascinating topic of: 'Veterinary Science and Translational Medicine', in particular how advances in veterinary science can often be highly valuable through translational applications.
Many of the medicines, procedures and surgical equipment that are currently in use for the treatment of animals were originally developed for human medicine, primarily because human therapy receives much more funding than veterinary medicine. However, this is not a one-way street, and advances in veterinary science can often be highly valuable to human medicine through translational medicine.
Speakers on the night so far include:
Professor Roberto La Ragione from the School of Veterinary Medicine,
University of Surrey, whose research focuses on antimicrobial resistance, vaccine development and the detailed mechanisms that bacterial pathogens of veterinary and medical importance employ to colonise animals and humans.
We will also hear from:
Erwin Blomsma, CEO of ViroVet who will talk about their fast acting antivirals and innovative vaccines for livestock and how they are being translated for human use.
Further speakers will be announced in due course.
18:00 Registration and networking
18:30 Welcome & Introductions
Dr Mark Hooper, Head of Business Development - OBN
Dr Anton Hutter, Chemical & Life Sciences Partner - Venner Shipley
19:00 Panel discussion :
Professor Roberto La Ragione, Head of the Department of Pathology and Infectious Diseases, Director of the Veterinary Pathology Centre, President of the Med-Vet-Net Association at the University of Surrey
Erwin Blomsma, Chief Executive Officer, ViroVet NV
20.00 Q&A session with the audience
20:30 - 21.30 Networking
University of Surrey
Daphne Jackson Road
OBN members: Free | OBN additional members: £25.00+VAT | Non-members: £50.00 + VAT.